Tag Archives: ONCE

Top 10 Low Price Stocks To Invest In 2019

Retirement investors want sure things. There isn’t enough time to make up for stocks that just fall into the ground, never to return. So considering how awful energy has been for the past couple of years, it’s probably surprising to see “energy stocks” and “retirement” mentioned in the same vicinity.

Sustained low oil and natural gas prices have negatively impacted energy stocks. OK, that’s putting it mildly. Low prices have outright strangled some companies right out of business, and has made life miserable for the vast majority of the sector.

See Also: Earn 5% to 11% With Master Limited Partnerships

And considering many retirement investors were sucked in by the plentiful dividends in the energy sector, they know the pain. And they’re probably not too forgiving.

Top 10 Low Price Stocks To Invest In 2019: MDU Resources Group, Inc.(MDU)

Advisors’ Opinion:

  • [By Shane Hupp]

    MDU Resources Group (NYSE: MDU) and Zenyatta Ventures (OTCMKTS:ZENYF) are both utilities companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk and dividends.

  • [By Logan Wallace]

    Forsta AP Fonden trimmed its holdings in MDU Resources Group Inc (NYSE:MDU) by 13.7% in the second quarter, according to its most recent disclosure with the SEC. The fund owned 64,700 shares of the utilities provider’s stock after selling 10,300 shares during the period. Forsta AP Fonden’s holdings in MDU Resources Group were worth $1,856,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Royal London Asset Management Ltd. bought a new position in MDU Resources Group Inc (NYSE:MDU) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 76,679 shares of the utilities provider’s stock, valued at approximately $2,199,000.

Top 10 Low Price Stocks To Invest In 2019: Century Aluminum Company(CENX)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Century Aluminum (CENX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Century Aluminum (CENX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Jon C. Ogg]

    Century Aluminum Co. (NASDAQ: CENX) was down 13.3% at $10.30, and it now has a new 52-week range of $10.13 to $24.77, with that low being put in on the same day.

Top 10 Low Price Stocks To Invest In 2019: Alexion Pharmaceuticals, Inc.(ALXN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Federated Investors Inc. PA reduced its stake in shares of Alexion Pharmaceuticals (NASDAQ:ALXN) by 86.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,571 shares of the biopharmaceutical company’s stock after selling 167,443 shares during the quarter. Federated Investors Inc. PA’s holdings in Alexion Pharmaceuticals were worth $2,960,000 at the end of the most recent quarter.

  • [By Chris Lange]

    Alexion Pharmaceuticals Inc.’s (NASDAQ: ALXN) short interest dropped to 4.37 million shares from the previous level of 5.01 million. Shares were trading at $116.70 in a 52-week range of $102.10 to $149.34.

  • [By Chris Lange]

    The Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) second-quarter report is scheduled for Thursday before the opening bell. The consensus forecast is $1.70 in EPS on $977.89 million in revenue. Shares ended the week at $135.27 apiece. The consensus price target is $158.89, and the 52-week range is $102.10 to $149.34.

  • [By Shane Hupp]

    Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) gapped up before the market opened on Tuesday after Stifel Nicolaus raised their price target on the stock from $130.00 to $136.00. The stock had previously closed at $127.35, but opened at $128.69. Stifel Nicolaus currently has a hold rating on the stock. Alexion Pharmaceuticals shares last traded at $128.94, with a volume of 50491 shares.

Top 10 Low Price Stocks To Invest In 2019: Ringcentral, Inc.(RNG)

Advisors’ Opinion:

  • [By Ethan Ryder]

    RingCentral Inc (NYSE:RNG) hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $91.15 and last traded at $90.75, with a volume of 25952 shares changing hands. The stock had previously closed at $88.65.

  • [By Anders Bylund]

    RingCentral (NYSE:RNG) led the way with a 26.3% surge, followed by 8×8 (NYSE:EGHT) at 13.8% and Vonage Holdings (NYSE:VG) scoring a 10.7% gain. All of these one-month returns crushed the broader market, as the S&P 500 benchmark notched just a 3% gain last month.

  • [By Rick Munarriz]

    One of last week’s biggest gainers was RingCentral (NYSE:RNG), moving 10% higher after posting another quarter of better-than-expected financial results. The strong report sent the shares to fresh all-time highs. The stock is now nearly a seven-bagger since going public at $13 five years ago. 

  • [By Shane Hupp]

    Shares of RingCentral (NYSE:RNG) were up 2.9% during trading on Friday after SunTrust Banks raised their price target on the stock to $80.00. SunTrust Banks currently has a buy rating on the stock. RingCentral traded as high as $81.20 and last traded at $74.55. Approximately 19,219 shares were traded during mid-day trading, a decline of 96% from the average daily volume of 485,528 shares. The stock had previously closed at $76.80.

  • [By Max Byerly]

    RingCentral Inc (NYSE:RNG) COO David Sipes sold 9,300 shares of RingCentral stock in a transaction on Wednesday, June 13th. The stock was sold at an average price of $77.71, for a total transaction of $722,703.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Top 10 Low Price Stocks To Invest In 2019: Foot Locker, Inc.(FL)

Advisors’ Opinion:

  • [By JJ Kinahan]

    With retail earnings season pretty much over, one key takeaway is how many so-called “brick-and-mortar” stores have found ways to keep customers coming in the doors rather than simply pointing and clicking. Many retailers had very good same-store sales, and what that shows is the traffic is still there for them. The challenge for retailers now is converting traffic to buyers, and retailers appear to have gotten much more creative and much better at helping their clients. About 70 percent of specialty retailers—which are smaller, niche-type stores—beat Wall Street’s forecasts for the quarter, according to Bloomberg research, and the S&P 500 Specialty Retail Index has actually outperformed the S&P 500 Internet Index since mid-March. Strong results reported by specialty retailers like Foot Locker, Inc. (NYSE: FL) and Tiffany & Co. (NYSE: TIF) last week have helped buttress the sector.

  • [By Ethan Ryder]

    Metropolitan Life Insurance Co. NY decreased its position in shares of Foot Locker, Inc. (NYSE:FL) by 7.3% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 17,852 shares of the athletic footwear retailer’s stock after selling 1,404 shares during the quarter. Metropolitan Life Insurance Co. NY’s holdings in Foot Locker were worth $940,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Stephan Byrd]

    BNP Paribas Arbitrage SA lowered its holdings in Foot Locker (NYSE:FL) by 18.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 158,165 shares of the athletic footwear retailer’s stock after selling 34,833 shares during the period. BNP Paribas Arbitrage SA owned approximately 0.13% of Foot Locker worth $7,203,000 as of its most recent SEC filing.

Top 10 Low Price Stocks To Invest In 2019: Dicerna Pharmaceuticals, Inc.(DRNA)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Agilent Technologies, Inc. (NYSE: A) is estimated to post quarterly earnings at $0.64 per share on revenue of $1.21 billion.
    Vipshop Holdings Limited (NYSE: VIPS) is expected to post quarterly earnings at $0.18 per share on revenue of $3.10 billion.
    Rexnord Corporation (NYSE: RXN) is projected to post quarterly earnings at $0.39 per share on revenue of $551.94 million.
    Invitation Homes Inc. (NYSE: INVH) is estimated to post quarterly earnings at $0.03 per share on revenue of $423.13 million.
    Switch, Inc. (NYSE: SWCH) is expected to post quarterly earnings at $0.05 per share on revenue of $99.83 million.
    Itron, Inc. (NASDAQ: ITRI) is projected to post quarterly earnings at $0.13 per share on revenue of $579.85 million.
    Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) is expected to post quarterly earnings at $0.44 per share on revenue of $119.06 million.
    Amyris, Inc. (NASDAQ: AMRS) is estimated to post quarterly earnings at $0.07 per share on revenue of $68.14 million.
    Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA) is projected to post quarterly loss at $0.38 per share on revenue of $1.87 million.
    VOXX International Corporation (NASDAQ: VOXX) is expected to post quarterly earnings at $0.05 per share on revenue of $130.00 million.
    Phoenix New Media Limited (NYSE: FENG) is estimated to post quarterly loss at $0.12 per share on revenue of $45.38 million.
    Restoration Robotics, Inc. (NASDAQ: HAIR) is projected to post quarterly loss at $0.17 per share on revenue of $5.93 million.
    YogaWorks, Inc. (NASDAQ: YOGA) is estimated to post quarterly loss at $0.22 per share on revenue of

  • [By Stephan Byrd]

    Spark Investment Management LLC reduced its position in shares of Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) by 30.9% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 100,200 shares of the biopharmaceutical company’s stock after selling 44,800 shares during the period. Spark Investment Management LLC owned about 0.19% of Dicerna Pharmaceuticals worth $1,227,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    Dicerna Pharmaceuticals (NASDAQ:DRNA) had its target price upped by research analysts at B. Riley from $10.00 to $13.50 in a research note issued on Monday, Stock Target Advisor reports. The brokerage presently has a “neutral” rating on the biopharmaceutical company’s stock. B. Riley’s price target indicates a potential downside of 20.26% from the company’s current price.

  • [By Shane Hupp]

    Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) insider James B. Weissman sold 2,301 shares of Dicerna Pharmaceuticals stock in a transaction dated Wednesday, September 5th. The stock was sold at an average price of $17.50, for a total value of $40,267.50. Following the sale, the insider now owns 26,781 shares in the company, valued at approximately $468,667.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Top 10 Low Price Stocks To Invest In 2019: Spark Therapeutics, Inc.(ONCE)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Spark Therapeutics (ONCE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Tower Semiconductor Ltd. (NASDAQ: TSEM) fell 16.1 percent to $23.10 in pre-market trading after reporting downbeat quarterly results.
    Integrated Media Technology Limited (NASDAQ: IMTE) fell 13 percent to $18.00 in pre-market trading after declining 37.37 percent on Friday.
    Ability Inc. (NASDAQ: ABIL) shares fell 7.1 percent to $2.61 in pre-market trading.
    International Flavors & Fragrances Inc. (NYSE: IFF) shares fell 6.4 percent to $133.00 in pre-market trading. International Flavors & Fragrances reported upbeat earnings for its first quarter and agreed to acquire Frutarom for $7.1 billion.
    BHP Billiton Limited (NYSE: BHP) fell 6.8 percent to $45.00 in pre-market trading.
    Sibanye Gold Limited (NYSE: SBGL) fell 6.4 percent to $3.23 in pre-market trading after dropping 2.27 percent on Friday.
    Spark Therapeutics, Inc. (NASDAQ: ONCE) fell 5.9 percent to $66.52 in pre-market trading after declining 1.15 percent on Friday.
    DENTSPLY SIRONA Inc. (NASDAQ: XRAY) shares fell 4 percent to $48.00 in pre-market trading. DENTSPLY SIRONA reported Q1 adjusted earnings of $0.45 per share on sales of $956.1 million. The company updated its 2018 adjusted earnings guidance to $2.55 to 2.65 per share

  • [By Logan Wallace]

    Spark Therapeutics (NASDAQ:ONCE) has been given a $103.00 target price by equities research analysts at Cantor Fitzgerald in a report released on Monday. The brokerage currently has a “buy” rating on the biotechnology company’s stock. Cantor Fitzgerald’s price target points to a potential upside of 111.85% from the stock’s current price.

  • [By Ethan Ryder]

    FIL Ltd cut its stake in Spark Therapeutics Inc (NASDAQ:ONCE) by 9.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 79,134 shares of the biotechnology company’s stock after selling 8,084 shares during the period. FIL Ltd owned approximately 0.21% of Spark Therapeutics worth $5,270,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Spark Therapeutics (ONCE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Low Price Stocks To Invest In 2019: Avnet, Inc.(AVT)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Avnet (AVT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Robeco Institutional Asset Management B.V. raised its holdings in Avnet (NYSE:AVT) by 36.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 64,627 shares of the technology company’s stock after purchasing an additional 17,261 shares during the period. Robeco Institutional Asset Management B.V. owned 0.05% of Avnet worth $2,772,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Avnet (AVT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    TLP Group LLC bought a new position in Avnet (NYSE:AVT) in the first quarter, HoldingsChannel reports. The fund bought 10,320 shares of the technology company’s stock, valued at approximately $431,000.

  • [By Stephan Byrd]

    DekaBank Deutsche Girozentrale raised its stake in Avnet (NYSE:AVT) by 763.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 72,310 shares of the technology company’s stock after purchasing an additional 63,936 shares during the period. DekaBank Deutsche Girozentrale owned about 0.06% of Avnet worth $3,050,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Top 10 Low Price Stocks To Invest In 2019: Samsung Electronics Co. Ltd. (SSNLF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Cirrus announced that the first product containing its new ANC chip last spring. In the most recent conference call, the company mentioned that it was in a new headset with a major OEM. A search looking for design breakdowns for Cirrus revealed two new products with Cirrus ANC inside. ABI Research reported finding the Cirrus ANC chip, 47L50C, inside replacing a chip from “Maxim MAX98730” The rest of the parts in the Studio 3 were the same as its predecessor Solo3. Beats increased the price on the Studio 3 by $50. ABI also found the 47L50C inside one of the new Samsung (OTC:SSNLF) products adding this statement, “Cirrus seems to be doing quite well in the ANC (Active noise cancellation) market as this is the second win we have seen (47L51b found in the Samsung ANC earbuds) in blooming ANC market.” There appear to be two new sets of earbuds from Samsung, a wired and a wireless. It is unclear to us which or perhaps both could have the new Cirrus chip inside. We know of at least three major brands with Cirrus ANC inside. The list continues to grow. We note we have yet to find a product with both parts, mics and codec. The four freshly washed E9s (ABBA) have eased the consist across the aligned switch onto the main with the semaphore straight up green-lighting the ANC Express and for those aboard, sensing the QUIET of the early morn.

  • [By ]

    Okay, let’s not devolve into an exciting technical discussion, other than to say there are two primary choices for the NAND offerings in production. Samsung (OTC:SSNLF), SK Hynix (OTC:HXSCF), Toshiba (OTCPK:TOSBF), and Western Digital (WDC) all developed their 3DNand using “Charge Trap” technology. But the Intel Micron Flash Technologies partners Intel (INTC) and Micron Technology (MU) selected “Floating Gate” and made sure to tell us how right they were and how wrong the other camp was.

  • [By ]

    ADT is taking aim at the resident-monitored market by partnering with technology provider Samsung (OTC:SSNLF) for a line of a do-it-yourself (DIY) home-security products. The products are supported by ADT’s monitoring service, and consumers can sign up for month-to-month plans. ADT will also integrate Ring Doorbells with its monitoring services if customers desire.

  • [By Jamal Carnette, CFA]

    While the news centered on Apple’s position slip, Samsung (NASDAQOTH:SSNLF) fared the worst of all major smartphone manufacturers when you drill further into the numbers. Smartphone shipments for Samsung fell 10.4% on a year-on-year basis, with Chinese competitors Huawei and Xiaomi appearing to take the lost market share. 

  • [By Anders Bylund]

    That would be South Korean memory giants Samsung (NASDAQOTH:SSNLF) and SK Hynix. Samsung controls nearly half the global market for DRAM chips while Hynix and Micron split the other half down the middle. Other chip manufacturers play a forgettable role in the total market. The NAND sector is a bit more diversified thanks to the presence of Western Digital (NASDAQ:WDC) and its all-important SanDisk subsidiary but Micron is one of the largest suppliers in this segment as well.

Top 10 Low Price Stocks To Invest In 2019: NewMarket Corporation(NEU)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on NewMarket (NEU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Here are some of the media stories that may have effected Accern’s rankings:

    Get NewMarket alerts:

    NewMarket’s (NEU) CEO Teddy Gottwald on Q2 2018 Results – Earnings Call Transcript (seekingalpha.com) NEU Crosses Below Key Moving Average Level (nasdaq.com) NewMarket misses by $1.15, misses on revenue (seekingalpha.com) NewMarket Corporation Reports Second Quarter and First Half 2018 Results (finance.yahoo.com) NewMarket: 2Q Earnings Snapshot (finance.yahoo.com)

    A number of equities research analysts have weighed in on NEU shares. TheStreet raised NewMarket from a “c” rating to a “b-” rating in a research report on Wednesday, April 25th. ValuEngine lowered NewMarket from a “hold” rating to a “sell” rating in a research report on Saturday, June 2nd.

  • [By Stephan Byrd]

    Royce & Associates LP increased its position in shares of NewMarket Co. (NYSE:NEU) by 0.6% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 26,362 shares of the specialty chemicals company’s stock after purchasing an additional 150 shares during the quarter. Royce & Associates LP owned 0.22% of NewMarket worth $10,663,000 as of its most recent filing with the SEC.

Top Medical Stocks To Invest In Right Now

Cyndee Weston can barely remember the last time she didn’t have to switch health plans during an Affordable Care Act sign-up season. By her count, she has been on five plans in five years.

Every fall, after she has spent months figuring out her insurance plan’s deductibles, doctor networks, list of covered drugs and other fine print, she receives notice that the policy will be canceled as of Dec. 31.

Because her job doesn’t come with insurance, “it’s agonizing going through all the plans and trying to compare,” said Weston, 55, who has diabetes and a history of melanoma. “Every year it’s the same scenario: ‘We’re not going to renew your policy.'”

Under the market-based system set up by the ACA, individuals are encouraged to “shop around” each year to find insurance that better suits their medical needs and income. In fact like Weston, a trade association executive in Sulphur, Okla. they are often forced to do so when plans drop out of the local market or eliminate preferred hospitals and doctors from the network.

Top Medical Stocks To Invest In Right Now: Spark Therapeutics, Inc.(ONCE)

Advisors’ Opinion:

  • [By Logan Wallace]

    Spark Therapeutics (NASDAQ:ONCE) was the target of some unusual options trading activity on Thursday. Investors acquired 551 put options on the company. This represents an increase of 884% compared to the average volume of 56 put options.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Spark Therapeutics (ONCE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Sean Williams, Chuck Saletta, and Brian Feroldi]

    So, which biotech stocks should you consider buying in June? That’s a question we posed to three of our healthcare-focused investors. Interestingly enough, mid-cap biotech stocks are the clear flavor of the month. If biotech is on your radar in June, our investors suggest you consider Ionis Pharmaceuticals (NASDAQ:IONS), Spark Therapeutics (NASDAQ:ONCE), and Alnylam Pharmaceuticals (NASDAQ:ALNY).

  • [By Cory Renauer]

    Here’s what you need to know about the catalysts that could send these stocks soaring, or plummeting, in the third quarter.

    Company Market Cap Incoming Catalyst
    Spark Therapeutics Inc. (NASDAQ:ONCE) $3.09 billion Clinical trial results
    Zogenix, Inc. (NASDAQ:ZGNX) $1.56 billion Clinical trial results
    Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) $593 million PDUFA date

    Data source: Yahoo! Finance.

  • [By Shane Hupp]

    Spark Therapeutics (NASDAQ:ONCE)‘s stock had its “market perform” rating reiterated by Leerink Swann in a research report issued on Monday, The Fly reports. They currently have a $74.00 price objective on the biotechnology company’s stock, up from their previous price objective of $55.00. Leerink Swann’s price objective would indicate a potential upside of 4.71% from the stock’s current price.

  • [By Ethan Ryder]

    FIL Ltd cut its stake in Spark Therapeutics Inc (NASDAQ:ONCE) by 9.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 79,134 shares of the biotechnology company’s stock after selling 8,084 shares during the period. FIL Ltd owned approximately 0.21% of Spark Therapeutics worth $5,270,000 at the end of the most recent reporting period.

Top Medical Stocks To Invest In Right Now: Northwest Biotherapeutics, Inc.(NWBO)

Advisors’ Opinion:

  • [By ]

    Northwest Biotherapeutics (OTC:NWBO) presented underwhelming preliminary data from a late-stage study of DCVax-L in brain cancer.

    Community Health Systems (NYSE:CYH) amended to extend the Early Tender Deadline and the Expiration Date for each Exchange Offer announced earlier.

  • [By ]

    The last time we left Northwest Biotherapeutics (OTC:NWBO), I stated in a fairly cautious article that there are persistent risks associated with an investment in this company. Back in November, I did not feel that the benefits outweighed the risks for this small cap equity.

Top Medical Stocks To Invest In Right Now: Dawson Geophysical Company(DWSN)

Advisors’ Opinion:

  • [By Max Byerly]

    Dawson Geophysical (NASDAQ:DWSN) was downgraded by equities researchers at ValuEngine from a “buy” rating to a “hold” rating in a research note issued on Monday.

  • [By Logan Wallace]

    Dawson Geophysical (NASDAQ:DWSN) was upgraded by stock analysts at TheStreet from a “d+” rating to a “c-” rating in a research note issued on Monday.

Top Medical Stocks To Invest In Right Now: TripAdvisor, Inc.(TRIP)

Advisors’ Opinion:

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Booking Holdings Inc. (NASDAQ: BKNG) to post quarterly earnings at $10.67 per share on revenue of $2.87 billion after the closing bell. Booking Holdings shares gained 0.99 percent to $2,183.00 in after-hours trading.
    Tripadvisor Inc (NASDAQ: TRIP) reported stronger-than-expected results for its first quarter on Tuesday. Tripadvisor shares climbed 20.55 percent to $46.75 in the after-hours trading session.
    Analysts are expecting Anheuser-Busch InBev SA/NV (NYSE: BUD) to have earned $0.89 per share on revenue of $13.06 billion in the latest quarter. Anheuser-Busch will release earnings before the markets open. Anheuser-Busch shares gained 0.77 percent to $99.00 in after-hours trading.
    Extreme Networks, Inc (NASDAQ: EXTR) reported downbeat earnings for its third quarter and issued weak Q4 guidance. Extreme Networks shares fell 28.51 percent to $8.40 in the after-hours trading session.
    Before the opening bell, Ameren Corporation (NYSE: AEE) is projected to report quarterly earnings at $0.57 per share on revenue of $1.55 billion. Ameren shares dropped 2.78 percent to close at $56.91 on Tuesday.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Dan Caplinger]

    The stock market jumped on Wednesday, with the Dow Jones Industrial Average finishing up by triple digits and other major benchmarks following suit with similar-sized gains. Attention once again focused on the oil market, where prices rebounded to climb to new multiyear highs above $71 per barrel. Investors seem to see oil’s strength as indicating stronger levels of economic activity, choosing not to fear any adverse pressure on prices that could result from higher costs for consumers and businesses that rely on energy products. Good news from several individual companies also helped keep sentiment positive. Axon Enterprise (NASDAQ:AAXN), TripAdvisor (NASDAQ:TRIP), and iQiyi (NASDAQ:IQ) were among the best performers on the day. Here’s why they did so well.

  • [By Demitrios Kalogeropoulos]

    TripAdvisor’s(NASDAQ:TRIP) business is barely growing, but Wall Street couldn’t be happier. The online travel booking specialist’s stock jumped over 20% immediately following its first-quarter earnings report that showed a 2% sales uptick while earnings fell 62% to $5 million.

  • [By Adam Levy]

    If you looked at the recent stock performances of TripAdvisor (NASDAQ:TRIP) and Booking Holdings (NASDAQ:BKNG), TripAdvisor has been, by far, the better investment. But zooming out to look at their respective price changes over the last several years tells a much different story.

  • [By Lisa Levin] Gainers
    Amedica Corporation (NASDAQ: AMDA) rose 31.3 percent to $4.11 in pre-market trading after climbing 181.98 percent on Tuesday.
    ZAGG Inc (NASDAQ: ZAGG) rose 18.7 percent to $13.65 in pre-market trading after the company posted better-than-expected Q1 earnings.
    TripAdvisor, Inc. (NASDAQ: TRIP) rose 18.6 percent to $46.00 in pre-market trading after the company reported stronger-than-expected results for its first quarter on Tuesday.
    TransEnterix, Inc. (NYSE: TRXC) shares rose 15 percent to $2.08 in pre-market trading after reporting Q4 results.
    Axon Enterprise, Inc. (NASDAQ: AAXN) rose 9.8 percent to $49.00 in pre-market trading following a big Q1 beat. The company raised its fiscal 2018 sales growth guidance from 16-18 percent to 18-20 percent.
    Centennial Resource Development, Inc. (NASDAQ: CDEV) shares rose 8.1 percent to $21.06 in pre-market trading following Q1 results.
    OPKO Health, Inc. (NASDAQ: OPK) shares rose 6.8 percent to $3.44 in pre-market trading following Q1 beat.
    Tel-Instrument Electronics Corp. (NYSE: TIK) rose 6.7 percent to $3.20 in pre-market trading after surging 25.37 percent on Tuesday.
    KBS Fashion Group Limited (NASDAQ: KBSF) rose 6.4 percent to $5.84 in pre-market trading after jumping 9.36 percent on Tuesday.
    Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) rose 6.6 percent to $8.26 in pre-market trading after reporting Q2 earnings.
    New Relic, Inc. (NYSE: NEWR) rose 6.3 percent to $82.00 in pre-market trading following Q4 results.
    Match Group, Inc. (NASDAQ: MTCH) rose 5.8 percent to $38.43 in pre-market trading after reporting upbeat Q1 earnings.
    Prestige Brands Holdings, Inc. (NYSE: PBH) rose 5.2 percent to $30.62 in pre-market trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Top Medical Stocks To Invest In Right Now: J & J Snack Foods Corp.(JJSF)

Advisors’ Opinion:

  • [By Stephan Byrd]

    ValuEngine upgraded shares of J & J Snack Foods (NASDAQ:JJSF) from a hold rating to a buy rating in a research note issued to investors on Tuesday.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on J & J Snack Foods (JJSF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on J & J Snack Foods (JJSF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Low Price Stocks To Own Right Now

The recent earning announcement on May 31, 2017 created sudden fear in the public’s mind and brought the stock price of Michael Kors (NYSE:KORS) down by around 9% in one day. As of this writing, the price remains at $33. In this article, I will discuss one negative and five positives, and explain why you should consider buying the stock at this low price.

One Negative

One negative, but a big one, that dragged down the stock price was the earning disappointment mainly driven by the macroeconomic situations in retail sector.

The entire retail sector has faced strong headwinds in recent years due to the emergence of online retailers (predominantly Amazon (NASDAQ:AMZN)), a strong dollar and a reduced number of tourists shopping in the U.S. The affected companies include Macy’s (NYSE:M), JCPenny (NYSE:JCP), Coach (NYSE:COH), Michael Kors, etc. The negative trends have driven down the stock price of the affected companies significantly in recent years, and the concern is legitimate in general,

Top 10 Low Price Stocks To Own Right Now: Patterson-UTI Energy, Inc.(PTEN)

Advisors’ Opinion:

  • [By Lee Jackson]

    This company remains a top oil services pick across Wall Street.Patterson-UTI Energy Inc. (NASDAQ: PTEN) is the second largest land driller in North America and a large pressure pumping provider. Its operations are particularly focused in the Marcellus and in Texas.

  • [By Stephan Byrd]

    Thrivent Financial for Lutherans increased its stake in Patterson-UTI (NASDAQ:PTEN) by 31.8% during the 1st quarter, Holdings Channel reports. The firm owned 3,073,057 shares of the oil and gas company’s stock after purchasing an additional 741,573 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Patterson-UTI were worth $53,810,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    First Pacific Advisors LLC decreased its holdings in Patterson-UTI Energy, Inc. (NASDAQ:PTEN) by 15.9% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,451,909 shares of the oil and gas company’s stock after selling 273,567 shares during the quarter. First Pacific Advisors LLC owned 0.65% of Patterson-UTI Energy worth $25,423,000 at the end of the most recent reporting period.

Top 10 Low Price Stocks To Own Right Now: Spark Therapeutics, Inc.(ONCE)

Advisors’ Opinion:

  • [By Tyler Crowe, Dan Caplinger, and Cory Renauer]

    Doubling your money in a relatively short time is much tougher. It typically involves investing in younger, less established companies that have lots of growth potential but could give a lot of ground if a few things don’t swing their way. There are, though, some stocks that look like they have a double in them over a relatively short time frame, and three of our investing contributors think Spark Therapeutics (NASDAQ:ONCE), Tractor Supply (NASDAQ:TSCO), and American Tower (NYSE:AMT) fit the bill.

  • [By Shane Hupp]

    Spark Therapeutics (NASDAQ:ONCE)‘s stock had its “market perform” rating reiterated by Leerink Swann in a research report issued on Monday, The Fly reports. They currently have a $74.00 price objective on the biotechnology company’s stock, up from their previous price objective of $55.00. Leerink Swann’s price objective would indicate a potential upside of 4.71% from the stock’s current price.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Spark Therapeutics (ONCE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Cory Renauer]

    It’s commendable to develop rare disease treatments that are so effective, some might call them “cures,” but that hardly guarantees market-beating returns. Let’s look into three companies with a hand in next-generation hemophilia treatments to see which has the best chance of coming out ahead.

    Company Market Capitalization Trailing-12-month Revenue
    Roche (NASDAQOTH:RHHBY) $188.6 billion $56.5 billion
    BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) $15.6 billion $1.38 billion
    Spark Therapeutics Inc. (NASDAQ:ONCE) $3.0 billion $26.4 million

    Data source: Yahoo! Finance.

  • [By Logan Wallace]

    Spark Therapeutics (NASDAQ:ONCE) was the target of some unusual options trading activity on Thursday. Investors acquired 551 put options on the company. This represents an increase of 884% compared to the average volume of 56 put options.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Tower Semiconductor Ltd. (NASDAQ: TSEM) fell 16.1 percent to $23.10 in pre-market trading after reporting downbeat quarterly results.
    Integrated Media Technology Limited (NASDAQ: IMTE) fell 13 percent to $18.00 in pre-market trading after declining 37.37 percent on Friday.
    Ability Inc. (NASDAQ: ABIL) shares fell 7.1 percent to $2.61 in pre-market trading.
    International Flavors & Fragrances Inc. (NYSE: IFF) shares fell 6.4 percent to $133.00 in pre-market trading. International Flavors & Fragrances reported upbeat earnings for its first quarter and agreed to acquire Frutarom for $7.1 billion.
    BHP Billiton Limited (NYSE: BHP) fell 6.8 percent to $45.00 in pre-market trading.
    Sibanye Gold Limited (NYSE: SBGL) fell 6.4 percent to $3.23 in pre-market trading after dropping 2.27 percent on Friday.
    Spark Therapeutics, Inc. (NASDAQ: ONCE) fell 5.9 percent to $66.52 in pre-market trading after declining 1.15 percent on Friday.
    DENTSPLY SIRONA Inc. (NASDAQ: XRAY) shares fell 4 percent to $48.00 in pre-market trading. DENTSPLY SIRONA reported Q1 adjusted earnings of $0.45 per share on sales of $956.1 million. The company updated its 2018 adjusted earnings guidance to $2.55 to 2.65 per share

Top 10 Low Price Stocks To Own Right Now: National Beverage Corp.(FIZZ)

Advisors’ Opinion:

  • [By Jeremy Bowman]

    The company appears to have solved that problem by remaking itself as a sparkling water brand. Not only does that make the product more attractive from a pricing perspective as it’s competing with more expensive bottled waters, but the company is now benefiting from tailwinds in consumer trends as more consumers are drinking bottled and sparkling water in part because of its perceived health benefits compared to soda.Shares ofNational Beverage(NASDAQ:FIZZ) have soared recently on the strength of LaCroix, the flavored sparkling water brand that has developed a following among millennials. In the U.S., sparkling water sales were expected to grow by more than a third last year and from 2011 to 2017 sales of the fizzy water.

  • [By Motley Fool Staff]

    But in the world of investing, it’s vital that we be able to trust the numbers companies report, and the Securities and Exchange Commission isn’t entirely sure we can when it comes to National Beverage (NASDAQ:FIZZ), seller of sparkling water LaCroix, as well as classic soda brands Faygo and Shasta. In essence, the SEC suggested that the company was being a bit too creative in terms of the metrics it was using to describe sales growth — possibly because the metrics themselves didn’t have a clear definition. So, what should Foolish investors think about all this? The guys have some advice.

  • [By Motley Fool Staff]

    In this segment from the Motley Fool Money podcast, host Chris Hill is joined by Jason Moser of Million Dollar Portfolio, David Kretzmann of Hidden Gems Canada, and Aaron Bush of Motley Fool Rule Breakers to discuss the stocks on their radar. Find out why National Beverage (NASDAQ:FIZZ), JPMorgan Chase (NYSE:JPM), and Autodesk (NASDAQ:ADSK) have piqued their interest.

  • [By Brian Feroldi]

    I’ve personally made several profitable investments over the last decade by simply observing my own buying habits. Here are a few recent examples:

    My family rarely eats out, but when we do we like to buy from healthier quick-service restaurants, such asChipotle (NYSE:CMG) or Panera Bread, instead of full-service restaurants or traditional fast food placesWendy’s or McDonald’s. My wife and I have eliminated soda from our lives. The only beverages that I drink now are water andStarbucks (NASDAQ:SBUX) coffee. My wife prefers to drink sparkling water like National Beverages’ (NASDAQ:FIZZ) La Croix brand. We mostly buy organic food and we love to shop at stores like Whole Foods (now owned by Amazon.com) and Trader Joes. We ditched cable a few years ago and now all of our entertainment needs aremet by streaming services that are offered by Amazon.com, Netflix, and Alphabet’s YouTube. Most of our household items and gifts that are purchased online at Amazon.com or Wayfair.

    I’d bet that if you reviewed your credit card statements, you’d quickly recognize a few patterns as well. Ask yourself: Are there anyretails stores or restaurant concepts that you frequent now but didn’t before? Are there any new foods or drinks that you now buy from the grocery store? Have you become a raving fan of a particular website or app?

  • [By Jamal Carnette, CFA]

    Against that backdrop, you might assume it’s best to avoid the soda industry altogether. However, there’s still a soda company for growth-oriented investors: National Beverage Group (NASDAQ:FIZZ).

Top 10 Low Price Stocks To Own Right Now: Emerson Electric Company(EMR)

Advisors’ Opinion:

  • [By Logan Wallace]

    D.A. Davidson & CO. lifted its position in shares of Emerson Electric (NYSE:EMR) by 1.3% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 574,584 shares of the industrial products company’s stock after buying an additional 7,640 shares during the period. Emerson Electric makes up about 0.8% of D.A. Davidson & CO.’s holdings, making the stock its 25th biggest holding. D.A. Davidson & CO.’s holdings in Emerson Electric were worth $39,244,000 at the end of the most recent reporting period.

  • [By Lee Samaha]

    In common with many other industrial companies, like Danaher, Pentair has been taking action to become a more focused investment proposition for investors. The sale of its valves and controls business to Emerson Electric (NYSE:EMR) in the spring of 2017 turned out to be well-timed for Emerson, as it occurred precisely at the time when oil and gas capital spending started picking up.

  • [By Stephan Byrd]

    Here are some of the headlines that may have effected Accern Sentiment Analysis’s analysis:

    Get Emerson Electric alerts:

    Stocks This Week: Wells Fargo, Emerson Electric and CSX (finance.yahoo.com) Emerson Electric (EMR) & Philips (PHG) Financial Review (americanbankingnews.com) Emerson Electric (EMR) Given Consensus Rating of “Hold” by Brokerages (americanbankingnews.com) Is It Time To Buy Emerson Electric Co (NYSE:EMR)? (finance.yahoo.com) Emerson Electric: An Autonomous Future (seekingalpha.com)

    EMR has been the topic of a number of research reports. Zacks Investment Research raised shares of Emerson Electric from a “hold” rating to a “buy” rating and set a $78.00 price objective on the stock in a research note on Thursday, February 8th. UBS initiated coverage on shares of Emerson Electric in a research note on Monday, January 22nd. They issued a “buy” rating and a $73.26 price objective on the stock. Cowen reissued a “buy” rating and issued a $78.00 price objective on shares of Emerson Electric in a research note on Wednesday, April 18th. Stifel Nicolaus increased their price objective on shares of Emerson Electric from $79.00 to $80.00 and gave the company a “buy” rating in a research note on Thursday, May 3rd. Finally, Berenberg Bank raised shares of Emerson Electric from a “sell” rating to a “hold” rating and set a $69.00 price objective on the stock in a research note on Tuesday, April 24th. They noted that the move was a valuation call. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and eight have given a buy rating to the stock. Emerson Electric has a consensus rating of “Hold” and a consensus price target of $73.00.

  • [By Benzinga News Desk]

    Former President George H.W. Bush has been hospitalized in Houston with an infection, just after attending the funeral of his wife, Barbara, a spokesman said Monday: Link

    ECONOMIC DATA
    Redbook Reports US Retail Sales During First 2 Weeks Of Apr. Up 0.3% MoM, Up 2.8% YoY
    USA S&P/CaseShiller House Price Index (MoM) for Feb Up 0.7% MoM
    New home sales report for March will be released at 10:00 a.m. ET.
    The Conference Board’s consumer sentiment index for April is schedule for release at 10:00 a.m. ET.
    The Richmond Fed manufacturing index for April will be released at 10:00 a.m. ET.
    The Treasury is set to auction 4-and 52-week bills at 11:30 a.m. ET.
    The Treasury will auction 2-year notes at 1:00 p.m. ET.
    ANALYST RATINGS
    Leerink upgraded Cardinal Health (NYSE: CAH) from Market Perform to Outperform
    Berenberg upgraded Emerson Electric (NYSE: EMR) from Sell to Hold
    Mizuho downgraded Skyworks (NASDAQ: SWKS) from Buy to Neutral
    BMO downgraded Texas Roadhouse (NASDAQ: TXRH) from Outperform to Market Perform

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.

  • [By Shane Hupp]

    Element Capital Management LLC acquired a new stake in Emerson Electric Co. (NYSE:EMR) in the 1st quarter, HoldingsChannel.com reports. The fund acquired 202,986 shares of the industrial products company’s stock, valued at approximately $13,864,000.

  • [By Neha Chamaria]

    The first list of Dividend Aristocrats published in 1989 comprised 26 stocks. Remarkably, nine of the 26 stocks are still part of the Dividend Aristocrat group.

    Dividend Aristocrat No. of Years of Consecutive Dividend Increases Payout Ratio (Last 12 Months) Current Dividend Yield
    Colgate-Palmolive Company (NYSE: CL) 55 67.6% 2.7%
    Dover Corp. (NYSE: DOV) 62 37.4% 2%
    Emerson Electric(NYSE: EMR) 60 69% 2.62%
    Genuine Parts Company(NYSE: GPC) 62 62.7% 3.12%
    Johnson & Johnson(NYSE: JNJ) 55 724.9% 2.57%
    Coca-Cola(NYSE: KO) 55 440.7% 3.5%
    Lowe’s Companies(NYSE: LOW) 55 37.4% 1.97%
    3M Company(NYSE: MMM) 60 70.4% 2.65%
    Procter & Gamble(NYSE: PG) 62 72.2% 3.94%

    Data source: S&P Global Market Intelligence, company financials, Yahoo Finance. Table by author.

Top 10 Low Price Stocks To Own Right Now: S&W Seed Company(SANW)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on S&w Seed (SANW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Neuberger Berman Group LLC raised its stake in S&W Seed (NASDAQ:SANW) by 43.6% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 73,415 shares of the company’s stock after purchasing an additional 22,293 shares during the period. Neuberger Berman Group LLC owned 0.30% of S&W Seed worth $264,000 as of its most recent SEC filing.

  • [By Ethan Ryder]

    Alico (NASDAQ: ALCO) and S&W Seed (NASDAQ:SANW) are both small-cap consumer staples companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, risk and dividends.

  • [By Logan Wallace]

    Alico (NASDAQ: ALCO) and S&W Seed (NASDAQ:SANW) are both small-cap consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, analyst recommendations and risk.

  • [By Ethan Ryder]

    S&w Seed (NASDAQ:SANW) – Equities researchers at B. Riley decreased their Q3 2019 earnings per share (EPS) estimates for S&w Seed in a research note issued to investors on Thursday, May 10th. B. Riley analyst S. Sherbetchyan now anticipates that the company will post earnings of $0.00 per share for the quarter, down from their previous forecast of $0.01. B. Riley has a “Buy” rating and a $5.50 price objective on the stock.

Top 10 Low Price Stocks To Own Right Now: Watsco, Inc.(WSO.B)

Advisors’ Opinion:

  • [By Shane Hupp]

    Watsco Inc Class B (NYSE:WSO.B) declared a quarterly dividend on Monday, July 2nd, NASDAQ reports. Stockholders of record on Tuesday, July 17th will be given a dividend of 1.45 per share by the construction company on Tuesday, July 31st. This represents a $5.80 annualized dividend and a dividend yield of 3.28%. The ex-dividend date of this dividend is Monday, July 16th.

Top 10 Low Price Stocks To Own Right Now: Reliance Steel & Aluminum Co.(RS)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Reliance Steel & Aluminum (RS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Reliance Steel & Aluminum Co. (NYSE:RS) saw a large increase in short interest in April. As of April 30th, there was short interest totalling 1,297,744 shares, an increase of 48.1% from the April 13th total of 876,450 shares. Approximately 1.9% of the shares of the stock are short sold. Based on an average trading volume of 568,500 shares, the short-interest ratio is presently 2.3 days.

  • [By Lisa Levin] Companies Reporting Before The Bell
    General Motors Company (NYSE: GM) is projected to report quarterly earnings at $1.24 per share on revenue of $34.66 billion.
    Bristol-Myers Squibb Company (NYSE: BMY) is estimated to report quarterly earnings at $0.85 per share on revenue of $5.24 billion.
    United Parcel Service, Inc. (NYSE: UPS) is expected to report quarterly earnings at $1.55 per share on revenue of $16.44 billion.
    Time Warner Inc. (NYSE: TWX) is projected to report quarterly earnings at $1.74 per share on revenue of $7.91 billion.
    ConocoPhillips (NYSE: COP) is expected to report quarterly earnings at $0.74 per share on revenue of $8.81 billion.
    PepsiCo, Inc. (NYSE: PEP) is expected to report quarterly earnings at $0.93 per share on revenue of $12.4 billion.
    American Airlines Group Inc. (NASDAQ: AAL) is estimated to report quarterly earnings at $0.72 per share on revenue of $10.42 billion.
    Southwest Airlines Co (NYSE: LUV) is expected to report quarterly earnings at $0.74 per share on revenue of $5.01 billion.
    Fiat Chrysler Automobiles N.V. (NYSE: FCAU) is estimated to report quarterly earnings at $0.8 per share on revenue of $34.52 billion.
    Union Pacific Corporation (NYSE: UNP) is projected to report quarterly earnings at $1.66 per share on revenue of $5.38 billion.
    D.R. Horton, Inc. (NYSE: DHI) is expected to report quarterly earnings at $0.85 per share on revenue of $3.76 billion.
    The Hershey Company (NYSE: HSY) is estimated to report quarterly earnings at $1.4 per share on revenue of $1.94 billion.
    Praxair, Inc. (NYSE: PX) is expected to report quarterly earnings at $1.56 per share on revenue of $2.94 billion.
    Altria Group, Inc. (NYSE: MO) is projected to report quarterly earnings at $0.92 per share on revenue of $4.63 billion.
    Shire plc (NASDAQ: SHPG) is estimated to report quarterly earnings at $3.54 per share on revenue of $3.72 billion.
    Oshkosh Corporation (NYSE: OSK) is projected to report quarter
  • [By Joseph Griffin]

    American Century Companies Inc. grew its stake in Reliance Steel & Aluminum Co (NYSE:RS) by 2.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 31,780 shares of the industrial products company’s stock after acquiring an additional 748 shares during the period. American Century Companies Inc.’s holdings in Reliance Steel & Aluminum were worth $2,725,000 at the end of the most recent reporting period.

Top 10 Low Price Stocks To Own Right Now: Net 1 UEPS Technologies, Inc.(UEPS)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results.
    MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results.
    ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million.
    Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results.
    Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results.
    VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71.
    Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results.
    Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results.
    Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739.
    Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69
  • [By Lisa Levin] Gainers
    Acacia Communications, Inc. (NASDAQ: ACIA) shares rose 18.3 percent to $37.25 in pre-market trading after gaining 1.74 percent on Friday.
    Kitov Pharma Ltd (NASDAQ: KTOV) rose 12.1 percent to $2.69 in pre-market trading after surging 4.80 percent on Friday.
    NXP Semiconductors N.V. (NASDAQ: NXPI) rose 10.9 percent to $109.75 in pre-market trading after Bloomberg reported that the China’s Commerce Ministry has restarted its review of QUALCOMM Incorporated’s (NASDAQ: QCOM) proposed takeover of NXP Semiconductors.
    Renewable Energy Group, Inc. (NASDAQ: REGI) rose 10.6 percent to $15.20 in pre-market trading. Renewable Energy will replace Synchronoss Technologies Inc. (NASDAQ: SNCR) in the S&P SmallCap 600 on Tuesday, May 15.
    NeoPhotonics Corporation (NYSE: NPTN) rose 10 percent to $6.40 in pre-market trading.
    Vaxart, Inc. (NASDAQ: VXRT) shares rose 8 percent to $5.54 in pre-market trading after gaining 2.19 percent on Friday.
    Profire Energy, Inc. (NASDAQ: PFIE) rose 7.3 percent to $4.58 in pre-market trading after gaining 6.22 percent on Friday.
    Marvell Technology Group Ltd. (NASDAQ: MRVL) rose 7 percent to $22.49 in pre-market trading after falling 1.96 percent on Friday.
    Oclaro, Inc. (NASDAQ: OCLR) shares rose 6.9 percent to $9.16 in pre-market trading.
    TransEnterix, Inc. (NYSE: TRXC) rose 5.7 percent to $2.24 in pre-market trading after gaining 3.92 percent on Friday.
    CVR Refining, LP (NYSE: CVRR) rose 5.4 percent to $19.70 in pre-market trading.
    Federal Agricultural Mortgage Corporation (NYSE: AGM) rose 5.2 percent to $92.95 in pre-market trading.
    International Game Technology PLC (NYSE: IGT) rose 5.2 percent to $29.94 in pre-market trading.
    Lumentum Holdings Inc. (NASDAQ: LITE) shares rose 5.1 percent to $66.30 in the pre-market trading session.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 5 percent to $10.70 in pre-market trading after climbing 15.66 percent on Friday.
    Finisar
  • [By Lisa Levin] Gainers
    MoSys, Inc. (NASDAQ: MOSY) shares rose 44.7 percent to $2.20 in pre-market trading after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    The Trade Desk, Inc. (NASDAQ: TTD) rose 23.2 percent to $65.01 in pre-market trading after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    Immersion Corporation (NASDAQ: IMMR) rose 17 percent to $13.55 in pre-market trading after reporting upbeat Q1 results.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) rose 13.8 percent to $23.50 in pre-market trading after the company disclosed that the FDA Advisory Committee voted in favor of WAYLIVRA for the treatment of familial chylomicronemia syndrome.
    RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 9.4 percent to $2.45 in pre-market trading after the company disclosed a collaboration with Iovance Biotherapeutics.
    ViewRay, Inc. (NASDAQ: VRAY) rose 13.7 percent to $8.80 in pre-market trading after reporting upbeat quarterly earnings.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 5.6 percent to $32.00 in pre-market trading after falling 2.26 percent on Thursday.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 5.6 percent to $9.30 in pre-market trading after reporting Q3 results.
    Aflac Incorporated (NYSE: AFL) rose 4.7 percent to $47.50 in pre-market trading.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 4.2 percent to $2.24 in pre-market trading following Q1 earnings.
    Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) shares rose 3.7 percent to $11.00 in pre-market trading after the company reported Q1 earnings.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Steve Symington]

    Shares of Net1 UEPS Technologies (NASDAQ:UEPS) jumped 15.7% on Friday after thealternative-payment systems specialist announced stronger-than-expected fiscal third-quarter 2018 results and an encouraging development regarding its social grants payments contract in South Africa.

Top 10 Low Price Stocks To Own Right Now: DigitalGlobe, Inc(DGI)

Advisors’ Opinion:

Top 10 Low Price Stocks To Own Right Now: New York Mortgage Trust Inc.(NYMT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Shares of NY Mtg Tr Inc/SH (NASDAQ:NYMT) have earned an average recommendation of “Hold” from the eight research firms that are presently covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and one has given a buy recommendation to the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $6.06.

Crispr Therapeutics: Assessing The Recent Capital Financing

The reason why the growth stocks do so much better is that they seem to show gains in value in the hundreds of percent each decade. In contrast, it is an unusual bargain that is as much as 50 percent undervalued. The cumulative effect of this simple arithmetic should be obvious. – Philip Fisher (the Father of Growth Investing)

On Jan 05, 2018, the share price of Crispr Therapeutics (NASDAQ:CRSP), a bioscience focusing on gene-editing and CAR-T to treat serious conditions such as cancers and genetic diseases, continued its rally. The stock added another $2.90 (over 12% profits) to value at $26.81 for the said trading session. Since we recommended the company on Nov. 27, 2017 (just over a month) to subscribers of Integrated BioSci Investing, the stock added another $7.26 (or 37% in capital appreciation). This robust run-up is interesting because, on Jan. 04, 2018, the company announced that the 5M additional common shares issued on Jan 03 will be priced at $22.75.

Figure 1: Crispr stock chart. (Source: Stockcharts).

At Integrated BioSci Investing (IBI), we have much success in finding robust performers. For instance, Nektar Therapeutics (NASDAQ:NKTR) appreciated over 200% for subscribers. Exelixis Inc procured over 50% profits. In this report, we’ll assess the ramifications of the recent financing and to reaffirm the investment thesis on Crispr.

Fundamentals Analysis

Back in 2017, there were several stellar medical breakthroughs that have ramifications that can be as far reaching as the introduction of chemotherapy more than a decade prior. Accordingly, the US FDA approved Yescarta (a CAR-T indicated for the treatment of non-Hodgkin lymphoma). The said molecule was innovated by Kite Pharma (NASDAQ:KITE) – a firm acquired by Gilead Sciences(NASDAQ:GILD). Moreover, the agency also approved the first gene therapy, Luxturna (voretigene neparvovec-rzyl), a molecule innovated by Sparks Therapeutics (NASDAQ:ONCE). It is a one-time treatment for patients afflicted with biallelic RPE65 mutation-associated retinal dystrophy.

In the midst of the aforesaid favorable regulatory environment for medical breakthroughs, the Switzerland-based company, Crispr Therapeutics is also brewing a revolutionary method of treating cancers and rare genetic diseases. As follows, CRISPR/Cas9 is a form of gene-editing currently being investigated in various conditions (as shown in the enriched pipeline in figure 2). The company also has a gene-editing enhanced form of CAR-T in development for various cancers. Of most interest is the lead molecule, CTX-001 (also a gene-editing therapeutic) that can be potentially used for the management of serious blood disorders: beta-thalassemia and sickle cell disease (SCD).

Figure 2: Therapeutic pipeline. (Source: Crispr).

Final Remarks

As alluded, Crispr recently issued another 5M common shares at the price of $22.75. The company also granted the underwriters a 30-day option to purchase up to 750K of its common shares. The expected gross proceeds from this offering are roughly $113.75M (excluding any exercise of the underwriters option to purchase additional shares). Moreover, the offering is expected to close on Jan. 09. The company employed Goldman Sachs (NYSE:GS), Piper Jaffray (NYSE:PJC), Barclays Capital (NYSE:BCS), and Guggenheim Securities as joint book-running managers for the said offerings. We strongly believe that the aforesaid capital financing is both strategic and prudent, as substantial capital (in the ballpark of over a billion dollars) is needed to fund a molecule from bench research to commercialization. With the share price appreciating, it is wise that the firm issued new shares to strengthen its capital for further pipeline innovation. There is an in-depth Integrated BioSci version of this research, which is available in advanced to subscribers of Integrated BioSci Investing.

Authors Notes: Were honored that you took the time out of your busy day to read our market intelligence. Founded by Dr. Hung Tran, MD, MS, CNPR, (in collaborations with Dr. Tran BioSci analyst, Ngoc Vu, and other PhDs), Integrated BioSci Investing (IBI) marketplace research is delivering stellar returns since inceptions. To name a few, Nektar Therapeutics (NASDAQ:NKTR) procured more than 210% profits; Spectrum Pharmaceuticals (NASDAQ:SPPI) delivered over 180% gains; Kite Pharma netted 82%. Exelixis Inc (NASDAQ:EXEL) earned greater than 50% capital appreciation. Our secret sauce is extreme due diligence coupled with expert data analysis. The service features a once-weekly exclusive in-depth Integrated BioSci Alpha-Intelligence article (in the form of research, reports, or interviews), daily individual stocks consulting, and model portfolios.

Notably, well increase our price soon. SUBSCRIBE to our marketplace research now to lock in the legacy price and save money in the future. To receive real-time alerts on our articles as well as blogs, be sure to check out our profile page and CLICK the orange FOLLOW button . Asides the exclusivities, this article is the truncated version of the research we published in advance to IBI subscribers. Further, you can read up on Dr. Trans background by following this link.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

About this article:ExpandAuthor payment: Seeking Alpha pays for exclusive articles. Payment calculations are based on a combination of coverage area, popularity and quality.Tagged: Investing Ideas, Long Ideas, Healthcare, Biotechnology, SwitzerlandWant to share your opinion on this article? Add a comment.Disagree with this article? Submit your own.To report a factual error in this article, click here

Top Stocks To Watch For 2018

Large cap upscale accessories retailer Coach Inc (NYSE: COH) reported FY17 Q4 and year end earnings before the market opened on Tuesday with shares falling off in premarket trading despite profit doubling. Q4 net sales totaled $1.13 billion versus $1.15 billion in the prior year. Excluding the additional week included in fiscal 2016 results, net sales increased 6% on a reported basis and 7% on a constant currency basis. The earnings release noted that as planned, the Companys strategic decision to elevate the Coach brands positioning in the North American wholesale channel through a reduction in promotional events and door closures negatively impacted sales growth by approximately 60 basis points in the quarter. Net income was $152 million versus net income of $82 million.

For fiscal year 2017, net sales totaled $4.49 billion versus $4.49 billion in the prior year. Excluding the additional week included in fiscal 2016 results, net sales increased 2% on both a reported and constant currency basis. Net income totaled $591 million on a reported basis versus reported net income of $461 million.

Top Stocks To Watch For 2018: Citrix Systems Inc.(CTXS)

Advisors’ Opinion:

  • [By Jim Robertson]

    At the beginning of the month, LogMeIn announced the completion of its merger with Citrix Systems, Inc (NASDAQ: CTXS) GetGo, Inc subsidiary.

    In late October, LogMeIn reported 22% third quarter revenue growth to $85.1 million and GAAP net loss was $0.7 million compared to a GAAP net income of $5.6 million. LogMeIn will report its fourth quarter and fiscal year 2016 financial results for the period ended December 31, 2016 following the close of market on February 28.

  • [By Ben Levisohn]

    Wynn Resortsgained 4.8% to $104.30 today, while the S&P 500 finished little changed at2,373.47. At 2:45, Wynn was easily the top performing stock in the S&P 500, only to be surpassed by Citrix’s (CTXS) late day surge.

  • [By Ben Levisohn]

    Citrix Systems (CTXS)soared nearly to the top of the S&P 500 today afterreports it had hired Goldman Sachs (GS) to pursue a sale of the company.

    S. MARTIN/AFP/Getty Images

    Citrix Systemsgained 6.8% to $84.93 today, while the S&P 500 finished little changed at 2,373.47.

    Business Insider’s Matt Weinbergerhas the details:

    Citrix, the $13 billion tech company best known for software like GoToMeeting, is working with Goldman Sachs to negotiate a possible sale, reports Bloomberg, citing anonymous sources.

    This isn’t the first time that Citrix has shopped itself around: in late 2015, and under pressure from activist shareholder Elliott Management, Citrix was said to have unsuccessfully tried to find a buyer.

    Citrix Systems market cap rose t0 $13.3 billion today from $12.4 billion on Friday. It reported net income of $536 million on sales of $3.4 billion in 2016.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Monday was Citrix Systems, Inc. (NASDAQ: CTXS) which jumped 6.8% to $84.93. The stocks 52-week range is $59.72 to $87.99. Volume was 5.19 million which is well above the daily average of around 2.09 million shares.

Top Stocks To Watch For 2018: Spark Therapeutics, Inc.(ONCE)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Wednesday, our Elite Opportunity Pronewsletter suggested going long again on small cap gene therapy stock Spark Therapeutics (NASDAQ: ONCE):

    Financially, Spark Therapeutics has over $300M in cash on the books and no debt to speak of yet, which equates to a share price of just over four times cash. The Company has generated over $20M in revenue for the trailing twelve months, and although the Company is expected to continue to lose money for the next few years, any strong clinical data that hits the tape could rocket shares of ONCE overnight, just like we’ve seen with so many others over the years.

  • [By Lisa Levin]

    Shares of Spark Therapeutics Inc (NASDAQ: ONCE) were down 36 percent to $47.08 on preliminary SPK-8011 trial data.

    Athenex Inc (NASDAQ: ATNX) was down, falling around 13 percent to $13.95. Almirall and Athenex reported a strategic partnership to develop and commercialize KX2-391 in the U.S. and Europe.

  • [By Chris Lange]

    Spark Therapeutics Inc. (NASDAQ: ONCE) saw its shares take a big step back on Monday after the firm reported less than favorable results at the American Society of Hematology (ASH) annual meeting. Analysts have taken this opportunity to weigh in on the stock:

  • [By Paul Ausick]

    Spark Therapeutics Inc. (NASDAQ: ONCE) dropped 44% Monday to post a new 52-week low of $41.06 after closing at $73.38 on Friday. The 52-week high is $91.75. Volume was around 13.5 million, nearly 30 times the daily average of about 480,000. The company’s hemophilia A drug posted disappointing trial results.

Top Stocks To Watch For 2018: VistaGen Therapeutics, Inc. (VTGN)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Four ideas turned up in this screen that might be of interest (prices as of February 9th close):

    Heron Therapeutics (NASDAQ:HRTX) by ONeil Trader – published February 3rd, 2017, $525M Market cap, down ~2% since publication, author’s price target offers 130% upside. HRTX isn’t a generic drug provider, but its CINV franchise vs. the growth of a new drug gives it a similar sort of profile, and arguably a favorable risk/reward; commenters were mostly positive on the thesis. VistaGen Therapeutics (OTC:VTGN) by Logical Assessment – published July 29, 2016, $24M market cap, down 16% since publication, author’s price target offers 100%+ upside. This is obviously deeper into the speculative pile, but if the author’s thesis holds about VistaGen’s unique angle in the antidepressant drug space, comparable deals suggest good upside. (Of course, it’s always dangerous to rely solely on comparables). Dr. Reddy’s Laboratories (NYSE:RDY) by Buddy Lyons – published July 5, 2016, $7.6B market cap, down ~13% since publication, author’s price target offers just shy of 100% upside. Dr. Reddy’s is a more obvious comparable to TEVA, with a generics business but also a manufacturing business and a proprietary products branch. The company bought a divestiture package of drugs from TEVA as part of the Allergan/Actavis deal. A big overhang was an FDA warning letter; the FDA is due to reinspect facilities this month or next, which could resolve that one way or another. Lannett (NYSEMKT:LCI) by Lateral Capital Management – published May 27, 2016, $750M market cap, down ~9% since publication, author’s price target offers 75% upside. LCI’s trading had been 90% correlated with Valeant, but Lateral Capital Management argues that the correlation is unjustified. The article does a deep dive into the company’s valuation and credit risk, and was well received at the time, even if the market hasn’t agreed…yet.

    I also checked to see if there are any ideas starting to play out on the short si

  • [By Money Morning News Team]

    Consider one of the top penny stocks from December,VistaGen Therapeutics Inc.(Nasdaq: VTGN). VTGN shares soared 156% in a single day of trading on Dec. 6.

  • [By William Romov]

    VistaGen Therapeutics Inc. (Nasdaq: VTGN) is among the top penny stocks to watch this week after climbing 135% in just three trading sessions last week.

  • [By Money Morning News Team]

    For instance, VistaGen Therapeutics Inc. (Nasdaq: VTGN) shot up from $0.92 to $2.55 on Dec. 6. Since then, the stock pulled back to $1.02. Investors who bought at $2.55 are sitting on a 60% loss today (Dec. 18).

  • [By Money Morning Staff Reports]

    For instance, VistaGen Therapeutics Inc. (Nasdaq: VTGN) shot up from $0.92 to $2.55 on Dec. 6. Since then, the stock pulled back to $1.07. Investors who bought at $2.55 are sitting on a 58% loss today (Jan. 8).

Top Stocks To Watch For 2018: iShares PHLX SOX Semiconductor Sector Index Fund(SOXX)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Marvell Technology Group peaking in early 2015 while peerSTMicroelectronics NV (NYSE: STM) hasnt performed much better and ETF benchmarks SPDR S&P Semiconductor ETF (NYSEARCA: XSD) and iShares PHLX SOX Semiconductor Sector (NASDAQ: SOXX) have performed better:

  • [By Peter Graham]

    A long term performance chart shows Marvell Technology Group giving investors and traders a bit of a roller-coaster ride while peerSTMicroelectronics NV (NYSE: STM) and ETF benchmarks SPDR S&P Semiconductor ETF (NYSEARCA: XSD) and iShares PHLX SOX Semiconductor Sector (NASDAQ: SOXX) really took off last year:

  • [By Peter Graham]

    A long term performance chart shows Marvell Technology Group along with peersSTMicroelectronics NV (NYSE: STM) and ETF benchmarks SPDR S&P Semiconductor ETF (NYSEARCA: XSD) and iShares PHLX SOX Semiconductor Sector (NASDAQ: SOXX)all taking offlast year albeit MRVL has underperformed ETF benchmarks:

  • [By Peter Graham]

    A long term performance chart shows Marvell Technology Group in an uptrend for the past two year, but also under performingpeerSTMicroelectronics NV (NYSE: STM) and ETF benchmarks SPDR S&P Semiconductor ETF (NYSEARCA: XSD) and iShares PHLX SOX Semiconductor Sector (NASDAQ: SOXX):

Top Stocks To Watch For 2018: ZIOPHARM Oncology Inc(ZIOP)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell by 0.88 percent. Meanwhile, top losers in the sector included Simulations Plus, Inc. (NASDAQ: SLP), down 7 percent, and ZIOPHARM Oncology Inc. (NASDAQ: ZIOP), down 7 percent.

  • [By Paul Ausick]

    Ziopharm Oncology Inc. (NASDAQ: ZIOP) dropped more than 10% Tuesday to post a 52-week low of $3.77 after closing at $4.20 on Monday. The 52-week high is $7.88. Volume was around 3.7 million, more than double the daily average. The company reported Tuesday on progress of two platforms it is developing and investors did not like what they heard.

Top Stocks To Watch For 2018: Winnebago Industries Inc.(WGO)

Advisors’ Opinion:

  • [By Elizabeth Balboa]

    Supply could come from any number of industry players, including Winnebago Industries, Inc. (NYSE: WGO), Thor Industries, Inc. (NYSE: THO), Polaris Industries Inc. (NYSE: PII) and Camping World Holdings Inc (NYSE: CWH). However, whether it comes from existing inventory and whether suppliers can meet the demand are yet to be seen.

  • [By Dan Caplinger]

    Friday was a good day on Wall Street, as the stock market responded favorably to encouraging news on the employment front. The U.S. unemployment rate dropped on fairly strong job creation during the month of February, and that helped push the Dow, S&P 500, and Nasdaq Composite to modest gains of roughly between a quarter percent and a half percent. Yet even with a positive mood among market participants, some stocks weren’t able to participate in the end-of-week rally. Finisar (NASDAQ:FNSR), Zumiez (NASDAQ:ZUMZ), and Winnebago Industries (NYSE:WGO) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

  • [By Peter Graham]

    The Q2 2017 earnings report for small cap motor home or RV stock Winnebago Industries, Inc (NYSE: WGO) is scheduled for before the market opens onWednesday (March 22nd). Back in2014, Winnebago Industries was in our SmallCap Network Elite Opportunity (SCN EO) portfolioas we believed the company would benefit from lower gas pricesalong with aBaby Boomer generation whos recreational retirement spending will increase. OurSCN EO newsletter noting at the time: